Metastatic gastric large cell neuroendocrine carcinoma: A case report and review of literature

Clinical Colorectal Cancer

Volumn 11, Issue 3, 2012, Pages 218-223

  Oberstein, Paul E ^a,b   Kenney, Barton ^a,b   Krishnamoorthy, Saravanan K ^a,b   Woo, Yanghee ^a,b   Saif, M Wasif ^a,b  

^a 6N 435 ^*  (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromogranin; Gastric carcinoma; Large cell neuroendocrine carcinomas; Neuroendocrine tumors; Synaptophysin

Indexed keywords

CARBOPLATIN; CHROMOGRANIN; EPIRUBICIN; IRINOTECAN; KI 67 ANTIGEN; OCTREOTIDE; PACLITAXEL; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR CDX2; YTTRIUM 90; ZOLEDRONIC ACID;

ABDOMINAL DISCOMFORT; ADD ON THERAPY; ADULT; ASPIRATION BIOPSY; BONE PAIN; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DIGESTIVE TRACT ENDOSCOPY; DRUG DOSE INCREASE; FOLLOW UP; GASTRIC LARGE CELL NEUROENDOCRINE CARCINOMA; HIP PAIN; HUMAN; LARGE CELL NEUROENDOCRINE CARCINOMA; LIVER METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SPINAL CORD METASTASIS; STOMACH BIOPSY; STOMACH TUMOR; THORAX PAIN; VERTEBRAL CANAL STENOSIS; WEIGHT REDUCTION;

EID: 84865453092     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2012.01.005     Document Type: Article

References (35)

1. W.D. Travis, R.I. Linnoila, M.G. Tsokos Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases Am J Surg Pathol 15 1991 529 553
2. C.A. Moran, S. Suster Neuroendocrine carcinomas (carcinoid, atypical carcinoid, small cell carcinoma, and large cell neuroendocrine carcinoma): current concepts Hematol Oncol Clin North Am 21 2007 395 407 vii
3. L.G. Larsson, L.R. Donner Large cell neuroendocrine carcinoma of the parotid gland: fine needle aspiration, and light microscopic and ultrastructural study Acta Cytol 43 1999 534 536
4. K.J. Patel, S.R. Chandana, D.A. Wiese Unusual presentation of large-cell poorly differentiated neuroendocrine carcinoma of the epiglottis J Clin Oncol 28 2010 e461 e463
5. I.I. Moisa Neuroendocrine tumors of the larynx Head Neck 13 1991 498 508
6. S. Mega, M. Oguri, R. Kawasaki Large-cell neuroendocrine carcinoma in the thymus Gen J Thorac Cardiovasc Surg 56 2008 566 569
7. A. Faggiano, J.C. Sabourin, M. Ducreux Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features Cancer 110 2007 265 274
8. M. Papotti, P. Cassoni, A. Sapino Large cell neuroendocrine carcinoma of the gallbladder: report of two cases Am J Surg Pathol 24 2000 1424 1428
9. T.C. Krivak, J.W. McBroom, M.J. Sundborg Large cell neuroendocrine cervical carcinoma: a report of two cases and review of the literature Gynecol Oncol 82 2001 187 191
10. S. Hailemariam, A. Gaspert, P. Komminoth Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder Mod Pathol 11 1998 1016 1020
11. A.J. Evans, P.A. Humphrey, J. Belani Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer Am J Surg Pathol 30 2006 684 693
12. A. Marici, M. Katunari, N. Sutalo Primary large-cell neuroendocrine carcinoma of the scrotum Wien Klin Wochenschr 122 2010 360 362
13. P. Theunissen, M. Fickers, R. Goei Primary large cell neuroendocrine carcinoma of the presacral region J Clin Pathol 54 2001 880 882
14. K. Matsui, X.M. Jin, M. Kitagawa Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants Arch Pathol Lab Med 122 1998 1010 1017
15. K.Y. Jang, W.S. Moon, H. Lee Gastric collision tumor of large cell neuroendocrine carcinoma and adenocarcinomaa case report Pathol Res Pract 206 2010 387 390
16. I.M. Modlin, C.J. Gilligan, G.P. Lawton Gastric carcinoids The Yale experience Arch Surg 130 1995 250 255 discussion:5-6
17. C.S. Landry, G. Brock, C.R. Scoggins A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients Ann Surg Oncol 16 2009 51 60
18. B. Lawrence, M. Kidd, B. Svejda A clinical perspective on gastric neuroendocrine neoplasia Curr Gastroenterol Rep 13 2011 101 109
19. G. Rindi, C. Azzoni, S. La Rosa ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis Gastroenterology 116 1999 532 542
20. O. Nilsson, E. Van Cutsem, G. Delle Fave Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic) Neuroendocrinology 84 2006 212 215
21. S.X. Jiang, T. Mikami, A. Umezawa Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity Am J Surg Pathol 30 2006 945 953
22. G. Rindi, C. Bordi, S. Rappel Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior World J Surg 20 1996 168 172
23. A. Iyoda, K. Hiroshima, T. Toyozaki Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features Cancer 92 2001 1108 1112
24. C.G. Moertel, L.K. Kvols, M.J. O'Connell Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin Evidence of major therapeutic activity in the anaplastic variants of these neoplasms Cancer 68 1991 227 232
25. E. Mitry, E. Baudin, M. Ducreux Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin Br J Cancer 81 1999 1351 1355
26. M.L. Fjllskog, D.P. Granberg, S.L. Welin Treatment with cisplatin and etoposide in patients with neuroendocrine tumors Cancer 92 2001 1101 1107
27. M.H. Kulke, B. Wu, D.P. Ryan A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors Dig Dis Sci 51 2006 1033 1038
28. J.D. Hainsworth, D.R. Spigel, S. Litchy Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study J Clin Oncol 24 2006 3548 3554
29. J.M. Varlotto, L.N. Medford-Davis, A. Recht Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas? J Thorac Oncol 6 2011 1050 1058
30. E. van Meerten, K. Muller, H.W. Tilanus Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study Br J Cancer 94 2006 1389 1394
31. S. Adams, R.P. Baum, A. Hertel Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: comparison with the expression of the Ki-67 antigen Nucl Med Commun 19 1998 641 647
32. T. Belhocine, J. Foidart, P. Rigo Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67 Nucl Med Commun 23 2002 727 734
33. R. Arnold, A. Rinke, K.J. Klose Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial Clin Gastroenterol Hepatol 3 2005 761 771
34. A. Rinke, H.H. Mller, C. Schade-Brittinger Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group J Clin Oncol 27 2009 4656 4663
35. P.L. Filosso, E. Ruffini, A. Oliaro Large-cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide J Thorac Cardiovasc Surg 129 2005 819 824